Ordering
Available Variants10 mg
CHA.30795-10mg
Price
€263.20
Available – Dispatch in 14 days
1 g
CHA.30795-1g
Price
€28.80
Available – Dispatch in 14 days
5 g
CHA.30795-5g
Price
€118.40
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
10 mg | CHA.30795-10mg | €263.20 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
1 g | CHA.30795-1g | €28.80 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 g | CHA.30795-5g | €118.40 |
97%
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C8H9NO3 |
|---|---|
| CAS Number | 42753-75-3 |
| Molecular Weight | 167.16 |
| NACRES | NA.22 |
| PubChem Substance ID | 24882782 |
| UNSPSC Code | 12352100 |
| MDL number | MFCD01317557 |
| Assay | 97% |
| Form | solid |
Safety Information Handling visibility
| pictograms |
GHS07
 GHS07
|
|---|---|
| signalword | Warning |
| hcodes | H302,H315,H317,H319,H335 |
| pcodes | P261 - P264 - P280 - P301 + P312 - P302 + P352 - P305 + P351 + P338 |
| Hazard Classifications | Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3 |
| target_organs | Respiratory system |
| Storage Class | 11 - Combustible Solids |
| wgk | WGK 2 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
| ppe | dust mask type N95 (US), Eyeshields, Faceshields, Gloves |
Technical Overview & Applications Use-case context
Methyl 5-aminosalicylate, with a CAS number of 23094-69-1, is a compound of interest in the field of pharmaceuticals, particularly in the treatment of inflammatory bowel diseases. It is a derivative of 5-aminosalicylic acid, where the carboxylic acid group is methylated, potentially altering its pharmacokinetic properties. This modification may influence its absorption, distribution, and metabolism within the body, which could have implications for its therapeutic efficacy and safety profile. Research into methyl 5-aminosalicylate focuses on its anti-inflammatory effects and its potential to reduce the severity of symptoms in conditions such as ulcerative colitis and Crohns disease. The compounds mechanism of action, involving the inhibition of inflammatory pathways, is a key area of study to understand its full therapeutic potential and to explore its possible uses in clinical settings. Further investigation is necessary to fully elucidate its properties and applications.
